Leaderboard

To all, This is a dream come true. https://www.clinicaltrials.gov/ct2/show/NCT04570475?sfpd_s=09%2F16%2F2020&sfpd_d=14 This is the gold standard RCT protocol I've been working with Dr. Mark Burish, MD, PhD., Will Erwin Headache Research Center, UT Houston School of Medicine to develop for almost a year at this point. We cut a lot of corners getting the protocol down to two pills with two look alike placebos and no loading dose, but I'm confident this dose will result in at least 70% of CHers responding with a significant reduction in the frequency of their CH during the course of this protocol. Take care, V/R, Batch

I had a chance to read through the online info at clinical trials. Any study like this is a lot of work because of the neuro ratio protections and generally inane people who serve on institutional review boards. As a starting point to collect data regarding safety of Vitamin D and the other factors it will be helpful. I am a bit skeptical that the time frame is adequate or that the studied will be powered enough to see the predicted outcome. More importantly because the evolution of the “Batch Protocol” has been ever tweaking what is being studied is certainly a stripped down version which may give a false negative. These things are so much work and only admiration can be extended to the instigator\/innovator for persistence and dedication. One last thought. Because the D3 dosing is fairly high from a conventional perspective it would be beneficial to find some pharmacologist looking to create safety data for high dose D3 much like has been done for psilocybin. But that’s another kettle of fish.